Envista Holdings Corp - NVST
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | President, Orthodontics | F | D | 7,710.0 | 27.47 | 211,793.7 | 48,806.0 | View | |
| Aug 27, 2026 | President, Diagnostics | F | D | 5,147.0 | 27.47 | 141,388.09 | 45,785.0 | View | |
| Aug 27, 2026 | Chief Financial Officer | F | D | 10,885.0 | 27.47 | 299,010.95 | 99,913.0 | View | |
| Aug 27, 2026 | President, Nobel Biocare | F | D | 804.0 | 27.47 | 22,085.88 | 61,560.0 | View | |
| Aug 24, 2026 | SVP, Strategy & Bus. Dev. | S | D | 8,000.0 | 27.5 | 220,000.0 | 27,321.0 | View | |
| Aug 20, 2026 | Chief Executive Officer | A | A | 159,900.0 | 0.0 | 0.0 | 159,900.0 | View | |
| Aug 20, 2026 | Chief Executive Officer | A | A | 179,730.0 | 0.0 | 0.0 | 551,304.0 | View | |
| Aug 20, 2026 | Chief Financial Officer | A | A | 47,970.0 | 0.0 | 0.0 | 47,970.0 | View | |
| May 27, 2026 | Chief Executive Officer | F | D | 12,811.0 | 23.43 | 300,161.73 | 371,574.0 | View | |
| May 21, 2026 | — | A | A | 9,330.0 | 0.0 | 0.0 | 59,940.0 | View | |
| May 21, 2026 | — | A | A | 9,330.0 | 0.0 | 0.0 | 52,945.0 | View | |
| May 21, 2026 | — | A | A | 9,330.0 | 0.0 | 0.0 | 54,010.0 | View | |
| May 21, 2026 | — | A | A | 9,330.0 | 0.0 | 0.0 | 18,485.0 | View | |
| May 21, 2026 | — | A | A | 9,330.0 | 0.0 | 0.0 | 54,010.0 | View | |
| May 21, 2026 | — | A | A | 12,585.0 | 0.0 | 0.0 | 82,105.0 | View | |
| May 21, 2026 | — | A | A | 9,330.0 | 0.0 | 0.0 | 59,930.0 | View |